Mark D Erion

Targeting thyroid hormone receptor-β agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index

Hongjian Jiang, M. Erion, P. D. van Poelje, 2007, Proceedings of the National Academy of Sciences.

Computer-aided drug design strategies used in the discovery of fructose 1, 6-bisphosphatase inhibitors.

M. Erion, M. R. Reddy, Mark D Erion, 2005, Current pharmaceutical design.

Relative binding affinities of fructose-1,6-bisphosphatase inhibitors calculated using a quantum mechanics-based free energy perturbation method.

M. Erion, Mark D Erion, M Rami Reddy, 2007, Journal of the American Chemical Society.

Development of a quantum mechanics-based free-energy perturbation method: use in the calculation of relative solvation free energies.

U. Singh, M. Erion, U C Singh, 2004, Journal of the American Chemical Society.

Free energy calculations to estimate ligand-binding affinities in structure-based drug design.

P Reddanna, R S Rathore, M. Erion, 2014, Current pharmaceutical design.

Advances in binding free energies calculations: QM/MM-based free energy perturbation method for drug design.

Allam Appa Rao, A. A. Rao, M Sumakanth, 2013, Current pharmaceutical design.